CD79A and autoimmune polyendocrinopathy: Part of the controversy regarding IgA aCL and aβ2GPI is due to the variable prevalence reported in cohorts.5 Some groups found significant clinical associations with thrombosis and APS diagnosis,2,6 whilst others did not.7